BASF recently witnessed its stock price surpassing the
two hundred day moving average, raising questions on whether it is time to sell. Despite this, the company is showing signs of growth with a recent
investment in a new Alcoholates Plant at its Ludwigshafen site and reported
strong net income growth for 2024. Nevertheless, Citi maintains a neutral stance setting the stock price target at EUR51.
Impairments continue to draw earnings lower and the anticipated
dividend has been indicated to shrink. Despite these setbacks, BASF is undertaking several strategic initiatives with strong Agro performance driving a buy rating. The company also revealed its plan to reduce carbon footprint with its new product,
Basotect EcoBalanced. However, recent
structural overhaul has prompted a dividend cut for the next four years. BASF continues to show promise in its offerings with the launch of its innovative technology for Retinol and the expansion of a sustainable product portfolio in Lemforde.
BASF Stocks News Analytics from Thu, 25 Apr 2024 07:00:00 GMT to Sat, 01 Mar 2025 18:09:51 GMT -
Rating -3
- Innovation 4
- Information 8
- Rumor 2
